Literature DB >> 23353003

Papain-induced in vitro disc degeneration model for the study of injectable nucleus pulposus therapy.

Samantha C W Chan1, Alexander Bürki, Harald M Bonél, Lorin M Benneker, Benjamin Gantenbein-Ritter.   

Abstract

BACKGROUND CONTEXT: Proteolytic enzyme digestion of the intervertebral disc (IVD) offers a method to simulate a condition of disc degeneration for the study of cell-scaffold constructs in the degenerated disc.
PURPOSE: To characterize an in vitro disc degeneration model (DDM) of different severities of glycosaminoglycans (GAG) and water loss by using papain, and to determine the initial response of the human mesenchymal stem cells (MSCs) introduced into this DDM. STUDY
DESIGN: Disc degeneration model of a bovine disc explant with an end plate was induced by the injection of papain at various concentrations. Labeled MSCs were later introduced in this model.
METHODS: Phosphate-buffered saline (PBS control) or papain in various concentrations (3, 15, 30, 60, and 150 U/mL) were injected into the bovine caudal IVD explants. Ten days after the injection, GAG content of the discs was evaluated by dimethylmethylene blue assay and cell viability was determined by live/dead staining together with confocal microscopy. Overall matrix composition was evaluated by histology, and water content was visualized by magnetic resonance imaging. Compressive and torsional stiffness of the DDM were also recorded. In the second part, MSCs were labeled with a fluorescence cell membrane tracker and injected into the nucleus of the DDM or a PBS control. Mesenchymal stem cell viability and distribution were evaluated by confocal microscopy.
RESULTS: A large drop of GAG and water content of the bovine disc were obtained by injecting >30 U/mL papain. Magnetic resonance imaging showed Grade II, III, and IV disc degeneration by injecting 30, 60, and 150 U/mL papain. A cavity in the center of the disc could facilitate later injection of the nucleus pulposus tissue engineering construct while retaining an intact annulus fibrosus. The remaining disc cell viability was not affected. Mesenchymal stem cells injected into the protease-treated DDM disc showed significantly higher cell viability than when injected into the PBS-injected control disc.
CONCLUSIONS: By varying the concentration of papain for injection, an increasing amount of GAG and water loss could be induced to simulate the different severities of disc degeneration. MSC suspension introduced into the disc has a very low short-term survival. However, it should be clear that this bovine IVD DDM does not reflect a clinical situation but offers exciting possibilities to test novel tissue engineering protocols.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23353003     DOI: 10.1016/j.spinee.2012.12.007

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  16 in total

1.  Development of an ex vivo cavity model to study repair strategies in loaded intervertebral discs.

Authors:  Zhen Li; Patrick Lezuo; Girish Pattappa; Estelle Collin; Mauro Alini; Sibylle Grad; Marianna Peroglio
Journal:  Eur Spine J       Date:  2016-04-01       Impact factor: 3.134

2.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

Review 3.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

4.  A large animal model that recapitulates the spectrum of human intervertebral disc degeneration.

Authors:  S E Gullbrand; N R Malhotra; T P Schaer; Z Zawacki; J T Martin; J R Bendigo; A H Milby; G R Dodge; E J Vresilovic; D M Elliott; R L Mauck; L J Smith
Journal:  Osteoarthritis Cartilage       Date:  2016-08-26       Impact factor: 6.576

5.  Development of a bovine decellularized extracellular matrix-biomaterial for nucleus pulposus regeneration.

Authors:  Svenja Illien-Jünger; Dillon D Sedaghatpour; Damien M Laudier; Andrew C Hecht; Sheeraz A Qureshi; James C Iatridis
Journal:  J Orthop Res       Date:  2015-12-01       Impact factor: 3.494

6.  Region specific response of intervertebral disc cells to complex dynamic loading: an organ culture study using a dynamic torsion-compression bioreactor.

Authors:  Samantha C W Chan; Jochen Walser; Patrick Käppeli; Mohammad Javad Shamsollahi; Stephen J Ferguson; Benjamin Gantenbein-Ritter
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

7.  Longitudinal Comparison of Enzyme- and Laser-Treated Intervertebral Disc by MRI, X-Ray, and Histological Analyses Reveals Discrepancies in the Progression of Disc Degeneration: A Rabbit Study.

Authors:  Marion Fusellier; Pauline Colombier; Julie Lesoeur; Samy Youl; Stéphane Madec; Olivier Gauthier; Olivier Hamel; Jérôme Guicheux; Johann Clouet
Journal:  Biomed Res Int       Date:  2016-05-10       Impact factor: 3.411

8.  Quantitative T2 mapping to characterize the process of intervertebral disc degeneration in a rabbit model.

Authors:  Wei Sun; Kai Zhang; Chang-qing Zhao; Wei Ding; Jun-jie Yuan; Qi Sun; Xiao-jiang Sun; You-zhuan Xie; Hua Li; Jie Zhao
Journal:  BMC Musculoskelet Disord       Date:  2013-12-18       Impact factor: 2.362

9.  Physiological loading can restore the proteoglycan content in a model of early IVD degeneration.

Authors:  Rahul Gawri; Janet Moir; Jean Ouellet; Lorne Beckman; Thomas Steffen; Peter Roughley; Lisbet Haglund
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

10.  An Inflammatory Nucleus Pulposus Tissue Culture Model to Test Molecular Regenerative Therapies: Validation with Epigallocatechin 3-Gallate.

Authors:  Olga Krupkova; Marian Hlavna; Julie Amir Tahmasseb; Joel Zvick; Dominik Kunz; Keita Ito; Stephen J Ferguson; Karin Wuertz-Kozak
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.